Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Idiopathic Pulmonary Fibrosis (BUILD 1)
NCT00071461Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Aug 2003
- Primary completion
- Sep 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of bosentan in idiopathic pulmonary fibrosis (IPF), sponsored by Actelion Pharmaceuticals Ltd. Started Aug 2003; status: completed.
02
Drugs
bosentan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00071461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071461.